Response of a KIT-positive extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis

被引：23
作者：
Goncalves, Anthony
Monges, Genevieve
Yang, Ying
Palmerini, Fabienne
Dubreuil, Patpice
Noguchi, Tetsuro
Jacquemier, Jocelyne
Di Stefano, Donatella
Delpero, Jean-Robert
Sobol, Hagay
Bertucci, Francois
机构：
[1] Inst J Paoli I Calmettes, Dept Med Oncol, F-13009 Marseille, France
[2] Inst Rech Canc Marseille, INSERM, UMR599, Marseille, France
[3] Inst J Paoli I Calmettes, Dept Biopathol, Dept Onco Genet, Marseille, France
[4] INSERM, UMR599, Lab Hematopoiese Mol & Fonct, Marseille, France
[5] Inst J Paoli I Calmettes, Dept Imagerie Med, Marseille, France
[6] Inst J Paoli I Calmettes, Dept Chirurg, Marseille, France
[7] Univ Mediterranee, Fac Med, Marseille, France
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2006年 / 98卷 / 08期
关键词：
D O I：
10.1093/jnci/djj137
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：562 / 563
页数：2
相关论文
共 7 条
[1]   Desmoid tumor: Prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy [J].
Ballo, MT ;
Zagars, GK ;
Pollack, A ;
Pisters, PWT ;
Pollock, RA .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :158-167
[2]   Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis [J].
Gega, M ;
Yanagi, H ;
Yoshikawa, R ;
Noda, M ;
Ikeuchi, H ;
Tsukamoto, K ;
Oshima, T ;
Fujiwara, Y ;
Gondo, N ;
Tamura, K ;
Utsunomiya, J ;
Hashimoto-Tamaoki, T ;
Yamamura, T .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) :102-105
[3]   Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia - potential clinical significance [J].
Inokuchi, K ;
Yamaguchi, H ;
Tarusawa, M ;
Futaki, M ;
Hanawa, H ;
Tanosaki, S ;
Dan, K .
LEUKEMIA, 2002, 16 (02) :170-177
[4]   The pharmacological treatment of aggressive fibromatosis: a systematic review [J].
Janinis, J ;
Patriki, M ;
Vini, L ;
Aravantinos, G ;
Whelan, JS .
ANNALS OF ONCOLOGY, 2003, 14 (02) :181-190
[5]   Response of extraabdominal desmoid tumors to therapy with imatinib mesylate [J].
Mace, J ;
Biermann, JS ;
Sondak, V ;
McGinn, C ;
Hayes, C ;
Thomas, D ;
Baker, L .
CANCER, 2002, 95 (11) :2373-2379
[6]  
Nagata H, 1996, EXP CLIN IMMUNOGENET, V13, P210
[7]  
Tayal S, 2005, ANTICANCER RES, V25, P2215
1